ANVISA registration 81325990416Valid until Nov 10, 2035HUMAN BRAIN NATRIURETIC PEPTIDE (BNP)
ANVISA Registration Number: 81325990416QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDAACRO BIOTECH, INC. (MONTCLAIR)Risk Class III
Device names
- Technical name
- HUMAN BRAIN NATRIURETIC PEPTIDE (BNP)
- Commercial name
- Família Cassete de teste para NT-proBNP (Sangue Total/Plasma)
- Risk class
- Class III
PT: PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Registration details
- Registration Number
- 81325990416
- Process Number
- 25351125671202590
- CNPJ
- 19933144000129
Company information
- Registration Holder
- QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA
- Manufacturer
- ACRO BIOTECH, INC. (MONTCLAIR)
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- Nov 10, 2025
- Validity
- 10/11/2035
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81325990416 and manufactured by ACRO BIOTECH, INC. (MONTCLAIR). The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until Nov 10, 2035.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.